Phase 5: Two-week Double-Blind phase Eligible subjects who have found an optimized dose during Phase 4, see above, will be randomized to receive their best dose of Aptensio XR® or matching placebo and will enter the two-week parallel Double-Blind Phase. Blinded study drug will be dispensed at visit 13 and double-blind treatment will follow on the morning after Visit 13.